Literature DB >> 17225060

Acne and PDT: new techniques with lasers and light sources.

Michael H Gold1.   

Abstract

Acne vulgaris is one of the most common dermatologic disorders encountered in everyday practice. Treatment options for this often psychologically scarring disease are numerous and, for many individuals, provide relief from the disorder. However, factors such as antibiotic resistance and slow onset of action from many topical therapies have led researchers to seek out alternative therapies, especially for those suffering from moderate to severe inflammatory acne vulgaris. Lasers and light sources are finding increased usage in the treatment of inflammatory acne vulgaris. Light sources including blue lights and intense pulsed lights are becoming regular additions to routine medical management to enhance the therapeutic response. Finally, photodynamic therapy may change many of the acne vulgaris paradigms, as its place is being defined in the treatment of moderate to severe inflammatory acne vulgaris. More and more clinical trials are showing the effectiveness of 5-aminolevulinic acid and photodynamic therapy in the treatment of moderate to severe inflammatory acne vulgaris.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17225060     DOI: 10.1007/s10103-006-0420-z

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   2.555


  34 in total

Review 1.  Photodynamic therapy in dermatology: history and horizons.

Authors:  Amy Forman Taub
Journal:  J Drugs Dermatol       Date:  2004 Jan-Feb       Impact factor: 2.114

2.  [Therapy of acne with visible light. Decreased irradiation time by using a blue-light high-energy lamp].

Authors:  H Meffert; K Gaunitz; T Gutewort; U J Amlong
Journal:  Dermatol Monatsschr       Date:  1990

Review 3.  Therapy for acne vulgaris.

Authors:  J J Leyden
Journal:  N Engl J Med       Date:  1997-04-17       Impact factor: 91.245

4.  Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation.

Authors:  Akira Kawada; Yoshinori Aragane; Hiroko Kameyama; Yoshiko Sangen; Tadashi Tezuka
Journal:  J Dermatol Sci       Date:  2002-11       Impact factor: 4.563

5.  Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients.

Authors:  Y Itoh; Y Ninomiya; S Tajima; A Ishibashi
Journal:  Br J Dermatol       Date:  2001-03       Impact factor: 9.302

6.  Photodynamic therapy for the treatment of acne: a pilot study.

Authors:  Amy Forman Taub
Journal:  J Drugs Dermatol       Date:  2004 Nov-Dec       Impact factor: 2.114

7.  A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.

Authors:  Michael H Gold; Jaggi Rao; Mitchel P Goldman; Tancy M Bridges; Virginia L Bradshaw; Molly M Boring; April N Guider
Journal:  J Drugs Dermatol       Date:  2005 Jan-Feb       Impact factor: 2.114

8.  The role of pulsed light and heat energy (LHE) in acne clearance.

Authors:  Monica Elman; Gary Lask
Journal:  J Cosmet Laser Ther       Date:  2004-06       Impact factor: 2.247

9.  Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate.

Authors:  Stine Regin Wiegell; Hans Christian Wulf
Journal:  J Am Acad Dermatol       Date:  2006-04       Impact factor: 11.527

10.  Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial.

Authors:  E D Seaton; A Charakida; P E Mouser; I Grace; R M Clement; A C Chu
Journal:  Lancet       Date:  2003-10-25       Impact factor: 79.321

View more
  10 in total

1.  [Incoherent light in dermatology].

Authors:  P Babilas; S Schreml; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2010-02       Impact factor: 0.751

2.  The Expressions of TGF-β(1) and IL-10 in Cultured Fibroblasts after ALA-IPL Photodynamic Treatment.

Authors:  Ji Yeon Byun; Ga Youn Lee; Hae Young Choi; Ki Bum Myung; You Won Choi
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

Review 3.  Photodynamic therapy for infections: clinical applications.

Authors:  Gitika B Kharkwal; Sulbha K Sharma; Ying-Ying Huang; Tianhong Dai; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

4.  Expression of IL-10, TGF-beta(1) and TNF-alpha in Cultured Keratinocytes (HaCaT Cells) after IPL Treatment or ALA-IPL Photodynamic Treatment.

Authors:  Ji Yeon Byun; Hae Young Choi; Ki Bum Myung; You Won Choi
Journal:  Ann Dermatol       Date:  2009-02-28       Impact factor: 1.444

Review 5.  Phototherapy and optical waveguides for the treatment of infection.

Authors:  Dingbowen Wang; Michelle Laurel Kuzma; Xinyu Tan; Tong-Chuan He; Cheng Dong; Zhiwen Liu; Jian Yang
Journal:  Adv Drug Deliv Rev       Date:  2021-11-03       Impact factor: 15.470

Review 6.  Photodynamic therapy for localized infections--state of the art.

Authors:  Tianhong Dai; Ying-Ying Huang; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2009 Sep-Dec       Impact factor: 3.631

7.  Efficacy of ipl in treatment of acne vulgaris : comparison of single- and burst-pulse mode in ipl.

Authors:  M Kumaresan; C R Srinivas
Journal:  Indian J Dermatol       Date:  2010-10       Impact factor: 1.494

8.  Photodynamic therapy inhibit Fibroblast Growth Factor-10 induced keratinocyte differentiation and proliferation through ROS in Fibroblast Growth Factor Receptor-2b pathway.

Authors:  Maya Valeska Gozali; Fei Yi; Jia-An Zhang; Juan Liu; Hong-Jin Wu; Yang Xu; Dan Luo; Bing-Rong Zhou
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

9.  Porphyrins as theranostic agents from prehistoric to modern times.

Authors:  Yumiao Zhang; Jonathan F Lovell
Journal:  Theranostics       Date:  2012-09-30       Impact factor: 11.556

10.  Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells.

Authors:  Pritam Thapa; Mengjie Li; Radha Karki; Moses Bio; Pallavi Rajaputra; Gregory Nkepang; Sukyung Woo; Youngjae You
Journal:  ACS Omega       Date:  2017-10-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.